Aimée Dallob
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 16
- Inflammatory mediators and NSAID effects 10
- Pharmacology and Obesity Treatment 2
- Treatment of Major Depression 2
- Co-authors
- Barry J. Gertz (5 shared papers)Stacia Kargman (1 shared paper)Chi‐Chung Chan (1 shared paper)Ian W. Rodger (1 shared paper)Elliot Ehrich (1 shared paper)Christine Brideau (1 shared paper)Eitan Friedman (3 shared papers)Jules I. Schwartz (6 shared papers)
- Journals
- The Journal of Clinical Pharmacology (4 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Inflammation Research (2 papers)Platelets (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Aimée Dallob
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 107
- Pharmacology 573
- Biochemistry 148
- Urology 60
- Pharmacology 85
- Cellular and Molecular Neuroscience 158
Countries citing papers authored by Aimée Dallob
This map shows the geographic impact of Aimée Dallob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimée Dallob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimée Dallob more than expected).
Fields of papers citing papers by Aimée Dallob
This network shows the impact of papers produced by Aimée Dallob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimée Dallob. The network helps show where Aimée Dallob may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimée Dallob, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 285 | |
| 2 | 1996 | 241 | |
| 3 | 2003 | 76 | |
| 4 | 1994 | 70 | |
| 5 | 2015 | 63 | |
| 6 | Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline. | 1979 | 54 |
| 7 | 1983 | 43 | |
| 8 | 2008 | 35 | |
| 9 | 1981 | 35 | |
| 10 | 1997 | 30 | |
| 11 | 2006 | 28 | |
| 12 | 1987 | 25 | |
| 13 | L-651,392: a novel, potent and selective 5-lipoxygenase inhibitor. | 1987 | 24 |
| 14 | 1990 | 24 | |
| 15 | 1987 | 23 | |
| 16 | 1979 | 21 | |
| 17 | 2011 | 19 | |
| 18 | 1989 | 18 | |
| 19 | 1994 | 16 | |
| 20 | 2010 | 14 |
About Aimée Dallob
Aimée Dallob is a scholar working on Pharmacology, Molecular Biology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Dementia and Cognitive Impairment Research (3 papers), Hormonal and reproductive studies (2 papers), Pharmacology and Obesity Treatment (2 papers) and Treatment of Major Depression (2 papers). The work is most often cited by research in Pharmacology (573 citations), Biochemistry (148 citations), Urology (60 citations), Pharmacology (85 citations) and Cellular and Molecular Neuroscience (158 citations). Aimée Dallob has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Barry J. Gertz, Stacia Kargman, Chi‐Chung Chan, Ian W. Rodger, Elliot Ehrich, Christine Brideau, Eitan Friedman, Jules I. Schwartz, Wesley Tanaka and Eitan Friedman. Their work appears in journals such as The Journal of Clinical Pharmacology, The Journal of Clinical Endocrinology & Metabolism, Inflammation Research, Platelets and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.